Open AccessA descriptive report of outcomes of primary mucinous ovarian cancer patients receiving either an adjuvant gynecologic or gastrointestinal chemotherapy regimen
Author(s) -
Brooke A. Schlappe,
Qin Zhou,
Roisin E. O’Cearbhaill,
Alexia Iasonos,
Robert A. Soslow,
Nadeem R. AbuRustum,
Jennifer J. Mueller
Publication year - 2019
Publication title -
international journal of gynecological cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.901
H-Index - 87
eISSN - 1525-1438
pISSN - 1048-891X
DOI - 10.1136/ijgc-2018-000150
Subject(s) - medicine , gynecologic oncology , cohort , gastrointestinal cancer , regimen , ovarian cancer , gastroenterology , chemotherapy regimen , chemotherapy , oncology , cancer , surgery , colorectal cancer
We described progression-free survival and overall survival in patients with primary mucinous ovarian cancer receiving adjuvant gynecologic versus gastrointestinal chemotherapy regimens.